
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1099 | 982 | 1013 | 661 | - | - |
Fund Return | 9.89% | -1.83% | 1.35% | -12.91% | - | - |
Place in category | 29 | 100 | 52 | 83 | - | - |
% in Category | 15 | 53 | 30 | 66 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
HSBC Jintrust Carbon Awareness Eq | 4.34B | 5.65 | -18.58 | 4.39 | ||
HSBC Jintrust New Engine MultiAsset | 3.32B | 4.31 | 4.97 | 5.24 | ||
HSBC Jintrust Dynamic Strategy H | 2.35B | 9.90 | -11.15 | - | ||
HSBC Jintrust Dynamic Strategy A | 2.35B | 9.90 | -11.07 | 11.13 | ||
Jintrust Large Cap Equity Sec Inv H | 2.31B | 4.25 | -4.12 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Zhongou Medical and Health Hybrid A | 32.09B | 0.38 | -16.27 | - | ||
Zhongou Medical and Health Hybrid C | 32.09B | 0.25 | -16.95 | - | ||
E Healthcare Secotor | 5.01B | 5.61 | 1.70 | 8.18 | ||
Fullgoal Precision Medical Mix Fund | 4.18B | 7.20 | -1.68 | - | ||
BOC Innovative Health Care Alloc | 3.01B | 15.67 | -1.43 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Suzhou Zelgen Biopharma | CNE100003RP1 | 9.79 | 99.35 | +1.20% | |
Keymed Biosciences Inc | - | 9.63 | - | - | |
Mabwell Shanghai Bioscience | CNE100005RD2 | 9.23 | 20.09 | -1.57% | |
Jiangsu Hengrui | CNE0000014W7 | 9.17 | 49.20 | +1.21% | |
Hansoh Pharmaceutical Group | KYG549581067 | 9.01 | 24.50 | +3.81% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review